Literature DB >> 21881826

PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.

Payal Ray1, Amar Kar, Kazuo Fushimi, Necat Havlioglu, Xiaoping Chen, Jane Y Wu.   

Abstract

Microtubule binding protein Tau has been implicated in a wide range of neurodegenerative disorders collectively classified as tauopathies. Exon 10 of the human tau gene, which codes for a microtubule binding repeat region, is alternatively spliced to form Tau protein isoforms containing either four or three microtubule binding repeats, Tau4R and Tau3R, respectively. The levels of different Tau splicing isoforms are fine-tuned by alternative splicing with the ratio of Tau4R/Tau3R maintained approximately at one in adult neurons. Mutations that disrupt tau exon 10 splicing regulation cause an imbalance of different tau splicing isoforms and have been associated with tauopathy. To search for factors interacting with tau pre-messenger RNA (pre-mRNA) and regulating tau exon 10 alternative splicing, we performed a yeast RNA-protein interaction screen and identified polypyrimidine tract binding protein associated splicing factor (PSF) as a candidate tau exon 10 splicing regulator. UV crosslinking experiments show that PSF binds to the stem-loop structure at the 5' splice site downstream of tau exon 10. This PSF-interacting RNA element is distinct from known PSF binding sites previously identified in other genes. Overexpression of PSF promotes tau exon 10 exclusion, whereas down-regulation of the endogenous PSF facilitates exon 10 inclusion. Immunostaining shows that PSF is expressed in the human brain regions affected by tauopathy. Our data reveal a new player in tau exon 10 alternative splicing regulation and uncover a previously unknown mechanism of PSF in regulating tau pre-mRNA splicing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881826      PMCID: PMC3893066          DOI: 10.1007/s12031-011-9634-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  108 in total

1.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

Review 2.  Mutations causing neurodegenerative tauopathies.

Authors:  Michel Goedert; Ross Jakes
Journal:  Biochim Biophys Acta       Date:  2005-01-03

3.  The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a direct interaction.

Authors:  T Straub; P Grue; A Uhse; M Lisby; B R Knudsen; T O Tange; O Westergaard; F Boege
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

4.  Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene.

Authors:  S M Pickering-Brown; A M T Richardson; J S Snowden; A M McDonagh; A Burns; W Braude; M Baker; W-K Liu; S-H Yen; J Hardy; M Hutton; Y Davies; D Allsop; D Craufurd; D Neary; D M A Mann
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

5.  Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors.

Authors:  A M Hartmann; D Rujescu; T Giannakouros; E Nikolakaki; M Goedert; E M Mandelkow; Q S Gao; A Andreadis; S Stamm
Journal:  Mol Cell Neurosci       Date:  2001-07       Impact factor: 4.314

6.  Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau.

Authors:  D Panda; B L Goode; S C Feinstein; L Wilson
Journal:  Biochemistry       Date:  1995-09-05       Impact factor: 3.162

Review 7.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

8.  Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.

Authors:  Yan Wang; Lei Gao; Sze-Wah Tse; Athena Andreadis
Journal:  Gene       Date:  2009-11-12       Impact factor: 3.688

9.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

10.  Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Authors:  M Goedert; M G Spillantini; M C Potier; J Ulrich; R A Crowther
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  23 in total

Review 1.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

2.  Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.

Authors:  Jolanta Lisowiec; Dorota Magner; Elzbieta Kierzek; Elzbieta Lenartowicz; Ryszard Kierzek
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 3.  Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Biochem Pharmacol       Date:  2014-01-10       Impact factor: 5.858

4.  Quantitative prediction of variant effects on alternative splicing in MAPT using endogenous pre-messenger RNA structure probing.

Authors:  Jayashree Kumar; Lela Lackey; Justin M Waldern; Abhishek Dey; Anthony M Mustoe; Kevin M Weeks; David H Mathews; Alain Laederach
Journal:  Elife       Date:  2022-06-13       Impact factor: 8.713

Review 5.  Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn.

Authors:  Nicole M Martinez; Kristen W Lynch
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

Review 6.  Alternative splicing in Alzheimer's disease.

Authors:  Angela Amato; Elisa Belloni; Anna Di Matteo; Lucia Infantino; Davide Pradella; Giuseppe Biamonti; Claudia Ghigna
Journal:  Aging Clin Exp Res       Date:  2019-10-03       Impact factor: 3.636

Review 7.  Regulation of alternative splicing of tau exon 10.

Authors:  Wei Qian; Fei Liu
Journal:  Neurosci Bull       Date:  2014-03-14       Impact factor: 5.203

8.  PSF contacts exon 7 of SMN2 pre-mRNA to promote exon 7 inclusion.

Authors:  Sunghee Cho; Heegyum Moon; Tiing Jen Loh; Hyun Kyung Oh; Darren Reese Williams; D Joshua Liao; Jianhua Zhou; Michael R Green; Xuexiu Zheng; Haihong Shen
Journal:  Biochim Biophys Acta       Date:  2014-03-14

9.  MicroRNAs and the Regulation of Tau Metabolism.

Authors:  Sébastien S Hébert; Nicolas Sergeant; Luc Buée
Journal:  Int J Alzheimers Dis       Date:  2012-06-05

10.  C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1.

Authors:  Chiranthani Sumanasekera; Olga Kelemen; Monique Beullens; Brandon E Aubol; Joseph A Adams; Manjula Sunkara; Andrew Morris; Mathieu Bollen; Athena Andreadis; Stefan Stamm
Journal:  Nucleic Acids Res       Date:  2011-12-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.